ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 126 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $110,000 | -75.3% | 69,391 | -42.7% | 0.01% | -68.4% |
| Q3 2018 | $446,000 | +6.4% | 121,100 | -18.1% | 0.02% | +18.8% |
| Q2 2018 | $419,000 | -49.2% | 147,900 | -33.5% | 0.02% | -42.9% |
| Q1 2018 | $825,000 | -14.9% | 222,500 | +3.0% | 0.03% | -12.5% |
| Q3 2017 | $970,000 | -2.1% | 216,000 | 0.0% | 0.03% | -20.0% |
| Q2 2017 | $991,000 | -18.2% | 216,000 | -25.0% | 0.04% | -37.5% |
| Q1 2017 | $1,212,000 | +47.1% | 288,000 | +44.4% | 0.06% | +18.5% |
| Q4 2016 | $824,000 | -64.3% | 199,431 | -30.0% | 0.05% | -60.0% |
| Q3 2016 | $2,308,000 | +3.6% | 284,900 | -0.2% | 0.14% | -23.3% |
| Q2 2016 | $2,228,000 | +1.3% | 285,600 | +0.2% | 0.18% | +27.5% |
| Q1 2016 | $2,199,000 | -8.5% | 284,900 | +28.0% | 0.14% | -58.1% |
| Q4 2015 | $2,402,000 | +145.6% | 222,600 | +124.4% | 0.33% | +1270.8% |
| Q1 2015 | $978,000 | +42.8% | 99,200 | +77.5% | 0.02% | -64.7% |
| Q4 2014 | $685,000 | +14.2% | 55,900 | -23.7% | 0.07% | +353.3% |
| Q2 2013 | $600,000 | – | 73,291 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |